Merck announced that the FDA has approved Janumet XR (sitagliptin/metformin HCl extended-release tablets) for the treatment of type 2 diabetes. Janumet XR is indicated as an adjunct to diet and ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today ...
Please provide your email address to receive an email when new articles are posted on . Extended-release metformin prolonged gestation compared with placebo in women who had preterm preeclampsia, ...
Interested in an oral alternative to Ozempic injections? You might be considering metformin, an FDA-approved type 2 diabetes medication that also results in weight loss. While a pill is certainly more ...
Objective: The purpose of this study was to determine the efficacy and safety of a novel extended-release metformin in patients with type 2 diabetes. Research Design And Methods: Adults with type 2 ...
The FDA has announced the recall of one brand of a popular type 2 diabetes drug, metformin, over a potentially cancer-causing impurity. Viona Pharmaceuticals, Inc. is voluntarily recalling 23 lots of ...
The drumbeat of US recalls continues for various lots of extended-release metformin due to contamination with unacceptably high levels of a nitrosoamine that pose a cancer risk. On December 28, Viona ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback